Paper4133079
The allogeneic effect: increased cellular immune and inflammatory responses.
Elfenbein GJ and 2 others. J Immunol, 1974. Cited by 16 papers, by iCite.
Cite this record
ConductScience Library. The allogeneic effect: increased cellular immune and inflammatory responses. Papers, record 4133079. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4133079
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics25
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Immunity, Cellular | Major topic |
| Inflammation | Major topic |
| Lymphocytes | Major topic |
| Transplantation Immunology | Major topic |
| Animals | |
| Arthus Reaction | |
| Ascitic Fluid | |
| Cattle | |
| Cell Migration Inhibition | |
| Croton Oil | |
| Dinitrophenols | |
| Guinea Pigs | |
| Immunization | |
| Lymph Nodes | |
| Lymphocyte Transfusion | |
| Lysine | |
| Macrophages | |
| Ovalbumin | |
| Serum Albumin, Bovine | |
| Skin | |
| Skin Tests | |
| Spleen | |
| Transplantation, Homologous | |
| Tritium | |
| gamma-Globulins |
Source PubMed
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 36831580 | Adjuvant Vaccination with Allogenic Dendritic Cells Significantly Prolongs Overall Survival in High-Grade Gliomas: Results of a Phase II Trial. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/36831580 | PubMed |
| 35628206 | Near-Complete Remission of Glioblastoma in a Patient Treated with an Allogenic Dendritic Cell-Based Vaccine: The Role of Tumor-Specific CD4+T-Cell Cytokine Secretion Pattern in Predicting Response and Recurrence. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35628206 | PubMed |
| 15185011 | Dendritic cell-tumor cell hybrid vaccination for metastatic cancer. | Cancer Immunol Immunother | 2004 | https://conductscience.org/library/papers/15185011 | PubMed |
| 7426375 | The inflammatory responses of rats depleted of lymphocytes or with an artificial obstruction of the thoracic duct. | Br J Exp Pathol | 1980 | https://conductscience.org/library/papers/7426375 | PubMed |
| 7340447 | Role of lymphocytes in non-immune experimental inflammation. | Agents Actions | 1981 | https://conductscience.org/library/papers/7340447 | PubMed |
| 738428 | Evidence for in vivo protection against a rat sarcoma by allogeneic spleen lymphocytes. | Experientia | 1978 | https://conductscience.org/library/papers/738428 | PubMed |
| 240373 | Survival of F1 hybrid rats inoculated with a strain specific transplantable carcinoma following the induction of a systemic graft-versus-host reaction. | Br J Cancer | 1975 | https://conductscience.org/library/papers/240373 | PubMed |
| 22486 | Demonstration and characterization of a serum factor produced by activated T cells. | Immunology | 1977 | https://conductscience.org/library/papers/22486 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/4133079
GET https://conductscience.org/api/papers/v1/4133079/authors